Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 10, 2018 07:00 ET | Source: Vivos Inc.

Vivos, Inc. Completes Common Stock Equity Financing to Fund Roll Out of IsoPet™ and Eliminate Toxic Debt

Richland WA, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos, Inc. a pharmaceutical company researching and developing minimally invasive treatments to combat cancer in humans...
October 02, 2018 07:00 ET | Source: Vivos Inc.

Vivos Inc Signs Memorandum of Understanding with Private Veterinary Hospital as Pilot Clinic for Commercial IsoPet® Therapy

Richland, WA, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) selected its first clinic for commercial sales of IsoPet Vivos Inc., a pharmaceutical company in the process of researching and...
May 31, 2018 06:00 ET | Source: Vivos Inc.

Vivos Inc Successfully Treats Canine Sarcoma with IsoPet™ (RadioGel™)

Richland, WA, May 31, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) successfully treated canine soft tissue sarcoma with its proprietary IsoPet™ (RadioGel™), a hydrogel liquid containing tiny...
May 01, 2018 09:00 ET | Source: Vivos Inc.

Vivos Demonstrates that IsoPet™ (RadioGel™) is effective in killing cancer in cats

Richland, WA, May 01, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today the results from the therapy for feline sarcoma. Five cats were treated at Washington...
March 20, 2018 09:30 ET | Source: Vivos Inc.

Vivos Adds Commercial Expertise to its Veterinary Medicine Advisory Board

Richland, WA, March 20, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it added a new member on the Veterinary Medicine Advisory Board. Tariq Shah BSc. DipMS is the...
January 30, 2018 09:00 ET | Source: Vivos Inc.

Vivos Receives FDA Confirmation of RadioGel Device Classification for Animal Skin Cancer Therapy

Richland, WA, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it has been notified by the FDA that RadioGel™ is classified as a device for animal therapy. ...
January 12, 2018 11:54 ET | Source: Vivos Inc.

Vivos Completes Planned Dosing Schedule for Feline Sarcoma Program

Richland, WA, Jan. 12, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it has completed its planned dosing schedule to determine the effectiveness of using the Company’s...